WASHINGTON, Aug. 14 /PRNewswire/ -- Aging, illness, stress, poor diet and the taking of antibiotics are just a few of the everyday ways in which our immune systems are depleted of the naturally occurring good bacteria that live in our digestive systems. Now launched in the United States, Multibionta Probiotic Multivitamin is the newest way to replenish the good bacteria in our bodies, which enhances the immune system, 70% of which is located in the intestines.
Multibionta, the first-ever clinically proven probiotic multivitamin, is comprised of a special three-in-one formulation including three different probiotic strains, as well as vitamins and minerals. Each tablet of Multibionta contains a blend of 10 million probiotics called TriBion Harmonis, including Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum MF 20/5, Bifidobacterium longum SP 07/3.
Referred to as the next generation multivitamin, Multibionta is the best- selling probiotic multivitamin sold throughout Europe. It is known for its three-layer tablet and the gastro-protective coating that ensures the probiotics remain effective throughout their journey from the mouth to the intestines where they are needed most. It can be taken anywhere, anytime, and be effective. Other sources of probiotics, such as yogurt, may not contain sufficient levels of probiotics to be effective and can lose effectiveness when they are exposed to heat and gastric acids as they make their journey into the stomach and into the intestines.
According to Dr. Glenn Gibson, Professor of Food Microbiology and head of the Food Microbiology Sciences Unit at the University of Reading, England, "A probiotic multivitamin with a gastro-protective coating ensures that a full delivery of probiotic cultures reach the gut intact and get to work immediately, to ensure a healthy, balanced digestive system."
Showcasing its immune defense abilities, a major clinical study conducted at University of Kiel in Germany proved that taking Multibionta Probiotic Multivitamin reduced the duration and severity of common cold symptoms by up to two days, in comparison to taking a multivitamin alone. In a separate trial, 42% of those who supplemented with a probiotic multivitamin reported a reduction in the incidence of digestive discomfort.
"Americans are just now learning about probiotics, how they help protect from harmful intestinal bacteria and the most effective way to take them," says dietician Kate Geagan MS, RD, who is a women's health consultant to Seven Seas, Multibionta's manufacturer. Geagan also notes, "Taking probiotics everyday can have significant health benefits, including enhanced digestion of food, reduction of the physical effects of Irritable Bowel Syndrome, as well as boosted resistance to illness and help combating life's daily stressors. With one in five women having IBS and millions more suffering from undiagnosed GI upset, Multibionta is a product that can significantly help alleviate the symptoms of an abnormal digestive system."
Multibionta Advanced Formula contains up to 100% of the recommended daily allowance of 23 vitamins and minerals, plus 10 million probiotic cultures. Multibionta 50+ combines all the probiotic, vitamin, and mineral benefits of Multibionta Advanced Formula with added herbal extracts important to aging including Bilberry, Ginseng and Lutein.
For more information about Multibionta, which is available exclusively at CVS/pharmacy, or to ask a question, visit http://www.multibionta.com.
Seven Seas first came onto the world market as the brand name for Cod Liver Oil in the UK in 1935. In the 1980s, Seven Seas expanded to vitamin and mineral supplements and has continued to grow its healthcare portfolio of brands through innovation and acquisition. In 1996, growth accelerated when Seven Seas changed ownership to come under the umbrella of German pharmaceutical giant Merck KGaA, Darmstadt, Germany.
Merck KGaA in Darmstadt is the oldest pharmaceutical and chemical company in the world, and still operates today in both the pharmaceutical and chemical sectors. It is not to be confused with Merck & Co, Whitehouse Station, New Jersey. The relationship with the two companies ended just after World War 1.
Merck KGaA's historical roots lie in Darmstadt (1668). It was in 1827 when a subsidiary was created in the United States, but became an independent American company (under the name Merck & Co) after World War 1.
The two companies are no longer linked to one another today -- the only thing they still have in common is the name Merck. Merck & Co holds the rights to the name within North America. Outside the region the US company operates as Merck Sharp and Dohme.
Merck KGaA in turn holds the rights elsewhere in the world and operates in North America under the umbrella brand EMD, formed from the initials of Emanuel Merck, Darmstadt. Worldwide, it has 168 companies in 54 countries with around 29,600 employees. Merck has focused its research and development in Darmstadt Germany although operations are also managed in France, Spain, Great Britain, the US and Japan.